Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis

被引：0
|
作者：
Kenji Omae
Tsunenori Kondo
Takafumi Kennoki
Toshio Takagi
Junpei Iizuka
Hirohito Kobayashi
Yasunobu Hashimoto
Kazunari Tanabe
机构：
[1] Tokyo Women’s Medical University,Department of Urology
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Renal cancer; End-stage renal disease; Prognosis; Survival; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：126 / 132
页数：6
相关论文
共 50 条
  • [21] Sorafenib rechallenge in patients with metastatic renal cell carcinoma
    Nozawa, Masahiro
    Yamamoto, Yutaka
    Minami, Takafumi
    Shimizu, Nobutaka
    Hatanaka, Yuji
    Tsuji, Hidenori
    Uemura, Hirotsugu
    BJU INTERNATIONAL, 2012, 110 (6B) : E228 - E234
  • [22] Efficacy of traditional and alternative sunitinib treatment schedules in Japanese patients with metastatic renal cell carcinoma
    Ohzeki, Takayuki
    Fukasawa, Satoshi
    Komaru, Atsushi
    Namekawa, Takeshi
    Sato, Yosuke
    Takagi, Kimiaki
    Kobayashi, Masayuki
    Uemura, Hirotsugu
    Ichikawa, Tomohiko
    Ueda, Takeshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (10) : 1065 - 1068
  • [23] Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma
    Nakano, Masahito
    Tanaka, Masatoshi
    Kuromatsu, Ryoko
    Nagamatsu, Hiroaki
    Sakata, Kenji
    Matsugaki, Satoru
    Kajiwara, Masahiko
    Fukuizumi, Kunitaka
    Tajiri, Nobuyoshi
    Matsukuma, Norito
    Sakai, Terufumi
    Ono, Noriyuki
    Yano, Yoichi
    Koga, Hironori
    Kurogi, Junichi
    Takata, Akio
    Sumie, Shuji
    Satani, Manabu
    Yamada, Shingo
    Niizeki, Takashi
    Aino, Hajime
    Iwamoto, Hideki
    Torimura, Takuji
    Sata, Michio
    ONCOLOGY, 2013, 84 (02) : 108 - 114
  • [24] Cardiac involvement in patients with sorafenib or sunitinib treatment for metastatic renal cell carcinoma
    Schmidinger, M.
    Vogl, U. M.
    Schukro, C.
    Bojic, A.
    Bojic, M.
    Schmidinger, H.
    Zielinski, C. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
    Schlemmer, Marcus
    Spek, Annabel
    Rodler, Severin
    Schott, Melanie
    Casuscelli, Jozefina
    Staehler, Michael
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (03)
  • [26] Efficacy and safety of intrapatient dose escalation of sorafenib as first-line treatment for metastatic renal cell carcinoma (mRCC).
    Gore, M. E.
    Jones, R. J.
    Ravaud, A.
    Kuczyk, M.
    Demkow, T.
    Bearz, A.
    Laferriere, N.
    Strauss, U. P.
    Porta, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review
    Leonetti, Alessandro
    Bersanelli, Melissa
    Castagneto, Bruno
    Masini, Cristina
    Di Meglio, Giovanni
    Pellegrino, Benedetta
    Buti, Sebastiano
    CLINICAL GENITOURINARY CANCER, 2016, 14 (04) : 277 - 283
  • [28] SUNITINIB AND SORAFENIB THERAPY FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (mRCC): SAFETY PROFILE
    Massari, Francesco
    Cricca, Antonia
    Sperandi, Francesca
    Martoni, Andrea Angelo
    ANTICANCER RESEARCH, 2010, 30 (04) : 1379 - 1380
  • [29] Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
    Yildiz, Ibrahim
    Sen, Fatma
    Kilic, Leyla
    Ciftci, Rumeysa
    Basaran, Mert
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (01) : 74 - 76
  • [30] Comparative Efficacy of Sunitinib versus Sorafenib as First-Line Treatment for Patients with Metastatic Renal Cell Carcinoma
    Park, Seong Joon
    Lee, Jae-Lyun
    Park, Inkeun
    Park, Kwonoh
    Ahn, Yongcheol
    Ahn, Jin-Hee
    Lee, Dae-Ho
    Ahn, Shin
    Song, Cheryn
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    CHEMOTHERAPY, 2012, 58 (06) : 468 - 474
12345